Literature DB >> 11062067

Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.

Y Fleming1, C G Armstrong, N Morrice, A Paterson, M Goedert, P Cohen.   

Abstract

Stress-activated protein kinase 1 (SAPK1), also called c-Jun N-terminal kinase (JNK), becomes activated in vivo in response to pro-inflammatory cytokines or cellular stresses. Its full activation requires the phosphorylation of a threonine and a tyrosine residue in a Thr-Pro-Tyr motif, which can be catalysed by the protein kinases mitogen-activated protein kinase kinase (MKK)4 and MKK7. Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1). For this reason, MKK4 and MKK7 together produce a synergistic increase in the activity of each SAPK1/JNK isoform in vitro. The MKK7 beta variant, which is several hundred-fold more efficient in activating all three SAPK1/JNK isoforms than is MKK7 alpha', is equally specific for Thr-183. MKK7 also phosphorylates JNK2 alpha 2 at Thr-404 and Ser-407 in vitro, Ser-407 being phosphorylated much more rapidly than Thr-183 in vitro. Thr-404/Ser-407 are phosphorylated in unstimulated human KB cells and HEK-293 cells, and phosphorylation is increased in response to an osmotic stress (0.5 M sorbitol). However, in contrast with Thr-183 and Tyr-185, the phosphorylation of Thr-404 and Ser-407 is not increased in response to other agonists that activate MKK7 and SAPK1/JNK, suggesting that phosphorylation of these residues is catalysed by another protein kinase, such as CK2, which also phosphorylates Thr-404 and Ser-407 in vitro. MKK3, MKK4 and MKK6 all show a strong preference for phosphorylation of the tyrosine residue of the Thr-Gly-Tyr motifs in their known substrates SAPK2a/p38, SAPK3/p38 gamma and SAPK4/p38 delta. MKK7 also phosphorylates SAPK2a/p38 at a low rate (but not SAPK3/p38 gamma or SAPK4/p38 delta), and phosphorylation occurs exclusively at the tyrosine residue, demonstrating that MKK7 is intrinsically a 'dual-specific' protein kinase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062067      PMCID: PMC1221441     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Selective interaction of JNK protein kinase isoforms with transcription factors.

Authors:  S Gupta; T Barrett; A J Whitmarsh; J Cavanagh; H K Sluss; B Dérijard; R J Davis
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  The search for physiological substrates of MAP and SAP kinases in mammalian cells.

Authors:  P Cohen
Journal:  Trends Cell Biol       Date:  1997-09       Impact factor: 20.808

3.  Selective activation of JNK/SAPK by interleukin-1 in rabbit liver is mediated by MKK7.

Authors:  A Finch; P Holland; J Cooper; J Saklatvala; M Kracht
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

4.  Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.

Authors:  M Goedert; A Cuenda; M Craxton; R Jakes; P Cohen
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

5.  Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.

Authors:  J Lisnock; P Griffin; J Calaycay; B Frantz; J Parsons; S J O'Keefe; P LoGrasso
Journal:  Biochemistry       Date:  2000-03-21       Impact factor: 3.162

6.  A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses.

Authors:  T Moriguchi; F Toyoshima; N Masuyama; H Hanafusa; Y Gotoh; E Nishida
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha.

Authors:  K S Walker; M Deak; A Paterson; K Hudson; P Cohen; D R Alessi
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

8.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

9.  Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro.

Authors:  S Lawler; Y Fleming; M Goedert; P Cohen
Journal:  Curr Biol       Date:  1998 Dec 17-31       Impact factor: 10.834

10.  Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.

Authors:  N W Freshney; L Rawlinson; F Guesdon; E Jones; S Cowley; J Hsuan; J Saklatvala
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

View more
  59 in total

Review 1.  Signal transduction networks in rheumatoid arthritis.

Authors:  D Hammaker; S Sweeney; G S Firestein
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase.

Authors:  Jaya Dasgupta; Supriya Kar; Rong Liu; Joy Joseph; Balaraman Kalyanaraman; S James Remington; Ceshi Chen; J Andres Melendez
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  Activation of SKN-1 by novel kinases in Caenorhabditis elegans.

Authors:  Alison Kell; Natascia Ventura; Nate Kahn; Thomas E Johnson
Journal:  Free Radic Biol Med       Date:  2007-09-07       Impact factor: 7.376

4.  Requirements for PKC-augmented JNK activation by MKK4/7.

Authors:  Pablo Lopez-Bergami; Ze'ev Ronai
Journal:  Int J Biochem Cell Biol       Date:  2007-12-03       Impact factor: 5.085

5.  c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.

Authors:  Qiangrong Liang; Orlando F Bueno; Benjamin J Wilkins; Chia-Yi Kuan; Ying Xia; Jeffery D Molkentin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

6.  RACK1 mediates activation of JNK by protein kinase C [corrected].

Authors:  Pablo López-Bergami; Hasem Habelhah; Anindita Bhoumik; Weizhou Zhang; Lu-Hai Wang; Ze'ev Ronai
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

7.  The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

Authors:  Jennifer Y Zhang; Maria Angelica Selim
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

8.  Integration of Caenorhabditis elegans MAPK pathways mediating immunity and stress resistance by MEK-1 MAPK kinase and VHP-1 MAPK phosphatase.

Authors:  Dennis H Kim; Nicole T Liberati; Tomoaki Mizuno; Hideki Inoue; Naoki Hisamoto; Kunihiro Matsumoto; Frederick M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

9.  Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.

Authors:  Susmita Mondal; Chandan Mandal; Rajender Sangwan; Sarmila Chandra; Chitra Mandal
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

10.  A non-redundant role for Drosophila Mkk4 and hemipterous/Mkk7 in TAK1-mediated activation of JNK.

Authors:  Peter Geuking; Rajesh Narasimamurthy; Bruno Lemaitre; Konrad Basler; François Leulier
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.